SR 11302 AP-1 Transcription Factor Inhibitor: Optimizing ...
2026-01-20
SR 11302, a selective AP-1 transcription factor inhibitor from APExBIO, revolutionizes cancer research by enabling targeted inhibition of tumor promotion with high specificity. Discover advanced protocols, troubleshooting insights, and real-world applications that make SR 11302 indispensable for dissecting the AP-1 signaling pathway and advancing chemoprevention strategies.